TrialCancer medicine2026

Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122.

Anthony T C Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.